NCT07334730

Brief Summary

This study aims to evaluate the effects of Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP), performed for the treatment of benign prostatic hyperplasia (BPH), on the following parameters: urinary continence, development of urethral or bladder neck stricture, and sexual function, including erectile function, ejaculation, and libido.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Feb 2026Oct 2026

First Submitted

Initial submission to the registry

December 31, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

January 12, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 31, 2025

Last Update Submit

December 31, 2025

Conditions

Keywords

HOLEPTHULEPBPOUrinary IncontinenceSexual FunctionUrethral StrictureBenign Prostate ObstructionBenign Prostate HyperplasiaHolmiumThulium

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with Postoperative Urethral Stricture or Urinary Incontinance

    Postoperative urethral stricture was defined as a maximum urinary flow rate (Qmax) of less than 15 mL/s on uroflowmetry at the first postoperative month, accompanied by a voiding curve pattern consistent with urethral obstruction. Postoperative urinary incontinence was defined as the presence of patient-reported urge or stress-type incontinence at the first postoperative month, supported by an increased score on the International Consultation on Incontinence Questionnaire (ICIQ)

    Within 6 months after surgery

Secondary Outcomes (3)

  • Number of participants assessed for sexual function

    within 6 months after surgery

  • Number of participants with surgery-related complications

    Within 6 months after surgery

  • Number of participants presenting with lower urinary tract symptoms

    Within 6 months after surgery

Study Arms (1)

Benign Prostatic Obstruction Patient Group

The effects of Holmium Laser Enucleation (HoLEP) and Thulium Laser Enucleation (ThuLEP) surgeries on continence, urethral stricture, and sexual function in patients with benign prostatic hyperplasia were investigated prospectively.

Eligibility Criteria

Age40 Years - 90 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsBenign prostatic obstruction is a male-specific condition
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult male patients treated surgically for benign prostatic obstruction.

You may qualify if:

  • Diagnosis of benign prostatic hyperplasia (BPH).
  • Indication for surgical treatment of BPH.
  • Male patients aged 40-90 years.

You may not qualify if:

  • Patients with active urinary tract infection (UTI).
  • Patients at high risk who cannot undergo spinal or general anesthesia.
  • Patients with uncontrolled bleeding diathesis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University Faculty of Medicine, Department of Urology

Kayseri, Melikgazi, 38140, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Urinary IncontinenceUrethral StrictureProstatic Hyperplasia

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrethral ObstructionUrethral DiseasesProstatic DiseasesGenital Diseases, MaleGenital Diseases

Study Officials

  • HALİL TOSUN, Assistant Professor

    TC Erciyes University

    PRINCIPAL INVESTIGATOR
  • EMRE C. AKINSAL, Assoc. Prof.

    TC Erciyes University

    STUDY CHAIR

Central Study Contacts

CEM DOĞAN, M.D.

CONTACT

HALİL TOSUN, Assistant Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Halil Tosun Assistant Proffessor

Study Record Dates

First Submitted

December 31, 2025

First Posted

January 12, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

January 12, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations